JT Stratford LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1689013 GAINESVILLE, GA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$479,502

-$119,294 QoQ

Shares Held

769

-0.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#818

of 1,322 holders

Holding Since

Sep 2021

20 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JT Stratford LLC holds $3,094,682 across 3 Biotechnology names. REGN ranks #3 (15.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,189	$2,080,801
2	INCY	Incyte Corp	4,714	$534,379
3	REGN	Regeneron Pharmaceuticals, Inc. This page	769	$479,502

20 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$479,502	769	-0.8%	Shares	Sole	2026-08-14
2026-03-31	$598,796	775	-4.1%	Shares	Sole	2026-05-15
2025-12-31	$623,670	808	-52.7%	Shares	Sole	2026-02-12
2025-09-30	$961,481	1,710	-39.4%	Shares	Sole	2025-11-12
2025-06-30	$1,482,075	2,823	-11.4%	Shares	Sole	2025-08-13
2025-03-31	$2,020,022	3,185	-6.4%	Shares	Sole	2025-05-14
2024-12-31	$2,424,058	3,403	+13.1%	Shares	Sole	2025-02-18
2024-09-30	$3,163,181	3,009	-2.7%	Shares	Sole	2024-11-14
2024-06-30	$3,250,835	3,093	+57.4%	Shares	Sole	2024-08-14
2024-03-31	$1,891,292	1,965	+32.0%	Shares	Sole	2024-05-14
2023-12-31	$1,307,773	1,489	+1.2%	Shares	Sole	2024-02-14
2023-09-30	$1,210,574	1,471	+35.1%	Shares	Sole	2023-11-14
2023-06-30	$782,490	1,089	-51.5%	Shares	Sole	2023-08-14
2023-03-31	$1,845,470	2,246	+13.1%	Shares	Sole	2023-05-10
2022-12-31	$1,432,157	1,985	+146.3%	Shares	Sole	2023-02-14
2022-09-30	$555,229	806	-13.5%	Shares	Sole	2022-11-14
2022-06-30	$550,933	932	+8.4%	Shares	Sole	2022-08-15
2022-03-31	$600,641	860	-23.8%	Shares	Sole	2022-05-12
2021-12-31	$712,354	1,128	+70.1%	Shares	Sole	2022-02-11
2021-09-30	$401,234	663	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.